Search clinical trials for: Furosemid hydrochlorothiazide

Total 645 results

Shiraz University of Medical Sciences

Completed

Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema

Edema | Nephrotic Syndrome
Corporacion Parc Tauli

Unknown

Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function (RRF)

Chronic Kidney Insufficiency | Hemodialysis Treatment | Diuresis Preserved

Spain
Capital Medical University

Recruiting

Use of Diuretics in Maintenance Hemodialysis Patients Undergoing Bioimpedance-guided Fluid Management

Diuretic Abuse

China
VA Office of Research and Development

Recruiting

Diuretics and Volume Overload in Early CKD (DOCK)

Hypertension | Chronic Kidney Disease

United States
Central Hospital, Nancy, France
Ministry of Health, France

Completed

Effects of Fluid Balance Control in Critically Ill Patients (POINCARE)

Critical Care | Fluid Shifts

France
Reprieve Cardiovascular, Inc

Not yet recruiting

EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU) (FASTR-EU)

Acute Decompensated Heart Failure

Netherlands, Poland
GlaxoSmithKline

Completed

A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide

Diabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus

United States
scPharmaceuticals, Inc.

Completed

Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

Heart Failure

United States
Novartis

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

Hypertension

United States
University of Sao Paulo General Hospital

Unknown

The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients

Chronic Kidney Disease | Secondary Hyperparathyroidism

Brazil
University Hospital, Clermont-Ferrand
Hospices Civils de Lyon; University Hospital, Grenoble; Hôpital de la Croix-Rousse and other collaborators

Recruiting

Protocol of Diuretics Use in Congestive Therapy in Heart Failure (ProDUCT-HF)

Heart Failure | Chronic Heart Failure | Acute Heart Failure

France
NYU Langone Health

Withdrawn

Nebulized Furosemide in Premature Infants With Bronchopulmonary Dysplasia - A Cross Over Pilot Study of Its Efficacy and Safety

Premature Birth | Premature Infant

United States
Insel Gruppe AG, University Hospital Bern

Completed

Hydrochlorothiazide for Kidney Stone Recurrence Prevention (NOSTONE)

Nephrolithiasis

Switzerland
Johns Hopkins University
scPharmaceuticals, Inc.

Completed

Sub-Q Versus IV Furosemide in Acute Heart Failure

Congestive Heart Failure

United States
Sanofi

Completed

Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis

Renal Failure

Canada
Yonsei University

Withdrawn

A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)

Congestive Heart Failure
GlaxoSmithKline

Completed

Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.

Diabetes Mellitus

France, Poland, Germany, Netherlands, Spain, Greece, Slovakia, Italy, United Kingdom, Denmark, Belgium, Norway, Canada, Israel
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mg

Healthy

United States
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study)

Heart Failure

United States, Canada
Hospital Infantil de Mexico Federico Gomez

Unknown

Comparison of the Impact of Diet vs Thiazide in BMD in Children With Idiopathic Hypercalciuria (HIC)

Nephrolithiasis | Hypercalciuria; Idiopathic

Mexico
University of North Carolina, Chapel Hill
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)

Bronchopulmonary Dysplasia

United States
Jan Kochanowski University

Recruiting

Prolonged Intravenous Therapy Versus Early Initiation of an Oral Loop Diuretic in Decompensated Heart Failure

Heart Failure

Poland
Vifor Pharma

Completed

A Drug-Drug Interaction Study of Furosemide and PA21

Healthy

United States
Daiichi Sankyo, Inc.

Completed

Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension

Essential Hypertension

Italy, Poland, Ukraine, Germany, Spain, Bulgaria, Romania, Denmark, Belgium, Netherlands, Russian Federation, Hungary, Slovakia, Czechia, Latvia
Medical Centre Leeuwarden

Completed

Hydrochloorthiazide and Hypernatriaemie

Hypernatraemia

Netherlands
Chiang Mai University

Recruiting

Protocol Based-furosemide Stress Test Versus Standard Care to Evaluate Renal Recovery During Continuous Renal Replacement Therapy (PAUSE-CRRT)

Acute Kidney Injury

Thailand
Stadtspital Zürich
Ospedale Regionale di Lugano

Recruiting

Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance (P-Value-AHF)

Acute Heart Failure | Diuretic Resistance

Switzerland
Puerta de Hierro University Hospital
Instituto de Salud Carlos III; Spanish Society of Cardiology

Completed

Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.

Heart Failure

Spain
Sir Mortimer B. Davis - Jewish General Hospital
Novartis Pharmaceuticals

Withdrawn

Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries

Hypertension | Diabetes

Canada
University of Siena
University of Roma La Sapienza; Azienda Ospedaliera di Padova; Ospedale Madonna...

Unknown

Loop Diuretic Therapy in Acutely Decompensated Heart Failure (DIUR-AHF)

Acute Heart Failure

Italy
University of Siena

Completed

Loop Diuretics Administration and Acute Heart Failure (diurHF)

Acute Heart Failure

Italy
Aspirus Heart and Vascular Institute-Research and...
Aspirus Wausau Hospital

Completed

Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure (REaCH)

Renal Insufficiency | Congestive Heart Failure

United States
Oregon Health and Science University

Withdrawn

Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis (SHUM)

Respiratory Failure | Hypernatremia | Volume Overload

United States
Unity Health Toronto

Unknown

The Use of Furosemide in Patients on Dialysis

End Stage Renal Disease

Canada
Daiichi Sankyo, Inc.

Completed

Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension

Essential Hypertension

France, Poland, Ukraine, Belgium, Germany, Spain, Bulgaria, Romania, Denmark, Russian Federation, Netherlands, Austria, Slovakia, Czechia
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers

Healthy
Sanofi

Completed

Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension (COSIMA2)

Hypertension

India, Malaysia, Philippines, Singapore, Taiwan, Tunisia, Egypt, Korea, Republic of, Hong Kong, Indonesia, Morocco, Pakistan, Thailand, Vietnam
Daiichi Sankyo, Inc.
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Essential Hypertension

France, Poland, Ukraine, Germany, Spain, Bulgaria, Czechia
Todd M Koelling, MD
scPharmaceuticals, Inc.

Withdrawn

A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen (DIVERSION-HF)

Acute Decompensated Heart Failure

United States
University of Palermo

Completed

Metabolic Effects of Furosemide +HSS in Refractory Ascites

Cirrhosis | Ascites

Italy
Spanish Society of Internal Medicine

Completed

Safety and Efficacy of the Combination of Loop With Thiazide-type Diuretics in Patients With Decompensated Heart Failure (CLOROTIC)

Heart Failure

Spain
University Hospital, Strasbourg, France

Suspended

Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria

Hypertension | End Stage Renal Disease | Proteinuria

France
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

Fed

India
University Medical Center Groningen

Not yet recruiting

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life (HYDRO-PROTECT)

ADPKD

Netherlands, United Kingdom, Belgium, Germany, France, Spain
Ranbaxy Laboratories Limited
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

Healthy
Boehringer Ingelheim

Completed

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Hypertension

United States
Larissa University Hospital

Terminated

Dopamine in Acute Decompensated Heart Failure II (DAD-HF II)

Acute Decompensated Heart Failure

United States, Greece
scPharmaceuticals, Inc.

Completed

Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration (FUROPHARM-HF)

Heart Failure

Netherlands
LTS Lohmann Therapie-Systeme AG

Completed

Magnetic Marker Monitoring of Furosemide-containing Gastroretentive Formulation in Healthy Male Subjects (Fasting and Fed Conditions)

Gastroretentive Drug Formulation of Furosemide | Oedema

Germany

Search clinical trials for: Furosemid hydrochlorothiazide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations